TYRA - Company ID 0001863127
Tyra Biosciences, Inc. trades as TYRA and has a market capitalization of $1.95 B, making it the #2159 largest US-listed company by market value. This page tracks Tyra Biosciences, Inc. through 393 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-12 |
| Insider trade | 4 | 2026-05-07 |
| Insider trade | 4 | 2026-05-07 |
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights | Tyra Biosciences, Inc.
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights | Tyra Biosciences, Inc.
The largest companies sharing Tyra Biosciences, Inc.'s SEC industry classification (pharmaceutical preparations).
Tyra Biosciences, Inc. (TYRA) has a market capitalization of $1.95 B as of 2026-07-09, ranking #2159 among US-listed companies.
In its latest fiscal year Tyra Biosciences, Inc. reported a net loss of $119.95M.